İNKONTİNANSLA İLİŞKİLİ DERMATİTİN ÖNLENMESİNDE İKİ FARKLI BAKIM ÜRÜNÜNÜN ETKİSİNİN İNCELENMESİ

Abstract

Amaç: İnkontinansla ilişkili dermatit (İİD) inkontinansı olan hastalarda ciddi bir sağlık sorunu olmaya devam etmektedir. İnme veya diğer nörolojik hastalıklardan sonra İİD gelişme riski artmaktadır. İİD’nin önlenmesi, cilt bütünlüğünün kontrolünü sağlama da oldukça önemlidir. Bu araştırmanın amacı, İİD’nin önlenmesinde kullanılan iki farklı bakım ürününün etkinliğini incelemektir. Gereç ve Yöntem: Deneysel tasarımda planlanan bu çalışmada; inkontinansı olan hastalar deney grubu (dimetikon pomad emdirilmiş mendil ile perineal bakım yapılan grup, n=66) ve kontrol grubuna (rutin olarak uygulanan sabunlu su ile perineal bakım yapılan grup, n=66) rastgele ayrıldı. İİD oranı değerlendirildi. Bu gruplara ait veriler karşılaştırıldı. Bulgular: Hastalar 10 gün takip edildi. Deney grubundaki hastaların %31,8’inde, kontrol grubundaki hastaların %40,9’unda İİD geliştiği görüldü. Ancak, anlamlı bir fark tespit edilmedi. Deney grubunda en çok genital bölge ile uyluk arasındaki çizgide (%15,2), kontrol grubunda labia/skrotumda (%27,3) İİD geliştiği gözlendi. Sıvı ve yarı şekilli dışkılama sayısı arttıkça İİD gelişiminde istatistiksel olarak anlamlı farklılık saptandı. Sonuç: İİD'nin önlenmesinde iki farklı bakım ürünü arasında istatistiksel olarak fark saptanmadı. Ancak hemşirelik bakımının sürdürülmesi adına bu çalışma önemlidir. Araştırmanın daha uzun süreli izlenerek inkontinansın sık görüldüğü kliniklerde tekrarlanması önerilebilir.

Keywords

• İnkontinans
• inkontinans ile ilişkili dermatit
• hemşirelik bakımı
• bakım ürünleri

EFFECT OF TWO DIFFERENT CARE PRODUCTS ON PREVENTION OF INCONTINENCE-ASSOCIATED DERMATITIS IN PATIENTS

Abstract

Objectives: Incontinent individuals continue to face a major health concern known as Incontinence-Associated Dermatitis (IAD). After a stroke or other neurological condition, the chance of developing IAD increases. Prevention of IAD is critical for maintaining skin integrity. The aim of this study was to examine the effectiveness of two different care products used in the prevention of IAD. Material and Methods: An experimental study was conducted. Incontinent patients were randomly assigned to one of two groups: intervention (experimental group received perineal treatment with dimethicone pomade impregnated wipes, n=66) or control (control group received perineal care with soapy water, n=66). The rate of IAD was determined. Results: During the 10-day follow-up period, 31.8% of the experimental group’s patients acquired IAD, whereas 40.9% of the control group’s patients got IAD. However, no significant change was observed. IAD was predominantly seen to grow on the curve between the genitals and the thigh in the experimental group (15.2%), whereas labia/scrotum was observed to develop in the control group (27.3%). According to the IAD development, there was a substantial difference in the number of semi-formed and liquid stools. Conclusion: There was no statistical difference between the two different care products in the prevention of IAD. However, it is important to study the continuation of nursing care. It may be recommended to repeat the study in clinics where incontinence is common, with a longer follow-up.

Keywords

• Incontinence
• incontinence-associated dermatitis
• nursing care
• care products

References

1. 1. Black JM, Gray M, Bliss DZ, Kennedy Evans KL, Logan S, Baharestani MM, et al. MASD Part 2: Incontinence-associated dermatitis and intertriginous dermatitis. J Wound Ostomy Continence Nurs 2011;38(3):303-15. google scholar
2. 2. Bliss DZ, Savik K, Thorson MA, Ehman SJ, Lebak K, Beilman G. Incontinence-associated dermatitis in critically ill adults: time to development, severity, and risk factors. J Wound Ostomy Continence Nurs 2011;38(4):433-45. google scholar
3. 3. Borchert K, Bliss D, Savik K, Radosevich DM. The incontinence-associated dermatitis and its severity instrument. J Wound Ostomy Continence Nurs 2010;37(5):527-35. google scholar
4. 4. Langemo D, Hanson D, Hunter S, Thompson P, Oh IE. Incontinence and incontinence-associated dermatitis. Adv Skin Wound Care 2011;24(3):126-40. google scholar
5. 5. Sugama J, Sanada H, Shigeta Y, Nakagami G, Konya C. Efficacy of an improved absorbent pad on incontinence-associated dermatitis in older women: cluster randomized controlled trial. BMC Geriatr 2012;12(1):1-7. google scholar
6. 6. Bliss DZ, Savik K, Harms S, Fan Q, Wyman JF. Prevalence and correlates of perineal dermatitis in nursing home residents. Nurs Res 2006;55(4):243-51. google scholar
7. 7. Beeckman D, Verhaeghe S, Defloor T, Schoonhoven L, Vanderwee K. A 3-in-1 perineal care wash cloth impregnated with dimethicone 3% versus water and pH neutral soap to prevent and treat incontinence-associated dermatitis: a randomized, controlled clinical trial. J Wound Ostomy Continence Nurs 2011;38(6):627-34. google scholar
8. 8. Gray M, Black JM, Baharestani MM, Bliss DZ, Colwell JC, Goldberg M, et al. Moisture-associated skin damage: overview and pathophysiology. J Wound Ostomy Continence Nurs 2011;38(3):233-41. google scholar

9. 9. Campbell JL, Coyer FM, Osborne SR. Incontinence-associated dermatitis: a cross-sectional prevalence study in the Australian acute care hospital setting. Int Wound J 2014;13(3):403-11. google scholar
10. 10. National Clinical Guideline Centre (UK). Urinary incontinence in neurological disease: management of lower urinary tract dysfunction in neurological disease. London: Royal College of Physicians (UK); 2012 Aug. https://www.ncbi.nlm.nih.gov/ pubmedhealth/PMH0055279/pdf/PubMedHealth_PMH0055279. pdf. google scholar
11. 11. Wiesel PH, Norton C, Roy AJ, Storrie JB, Bowers J, Kamm MA. Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. J Neurol Neurosurg Psychiatry Res 2000;69(2):240-3. google scholar
12. 12. Tülek Z. Mesane ve Bağırsak Sorunlarının Değerlendirilmesi ve Yönetimi. İçinde: Topçuoğlu M, Durna Z, Karadakovan A, editors. Nörolojik Bilimler Hemşireliği Kanıta Dayalı Uygulamalar. İstanbul: Nobel Tıp Kitapevleri 2013.p.283-99. google scholar
13. 13. Leandro TA, Araujo TLD, Cavalcante TF, Lopes MVDO, Oliveira TMFD, Lopes ACM. Urinary incontinence nursing diagnoses in patients with stroke. Rev Esc Enferm USP 2015;49(6):923-30. google scholar
14. 14. Uraloğlu G, Selçuk B, Kurtaran A, Yalcin E, Inanir M, Sade I, Akyüz M. Assessment of the bowel dysfunctions in stroke patients. Turk J Geriatr 2014;17(4):330-7. google scholar
15. 15. Hall KD, Clark RC. A prospective, descriptive, quality improvement study to decrease incontinence-associated dermatitis and hospital-acquired pressure ulcers. Ostomy/Wound Manag 2015;61(7):26-30. google scholar
16. 16. Nix DH. Validity and reliability of the perineal assessment tool. Ostomy/Wound Manag 2002;48(2):43-9. google scholar
17. 17. Beeckman D, Woodward S, Gray M. Incontinence-associated dermatitis: step-by-step prevention and treatment. Br J Nurs 2011;16(8):382-9. google scholar
18. 18. Johnson D, Lineweaver L, Maze LM. Patients’ bath basins as potential sources of infection: a multi center sampling study. Am J Crit Care 2009;18(1):31-40. google scholar
19. 19. Beeckman D, Van Damme N, Schoonhoven L, Van Lancker A, Kottner J, Beele H, et al. Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database Syst Rev 2016;11:1-72. google scholar
20. 20. Coyer F, Campbell J. Incontinence-associated dermatitis in the critically ill patient: an intensive care perspective. Intensive Crit Care Nurs 2017;23(4):198-206. google scholar
21. 21. Ma ZZ, Song JY, Wang M. Investigation and analysis on occurrence of incontinence-associated dermatitis of ICU patient with fecal incontinence. Int J Clin Exp Med 2017;10(5):7443-9. google scholar
22. 22. Denat Y, Khorshid L. The effect of 2 different care products on incontinence-associated dermatitis in patients with fecal incontinence. J Wound Ostomy Continence Nurs 2011;38(2):171-6. google scholar
23. 23. Aydın GÖ, Kaya H. Incontinence associated dermatitis assessment scale: study of inter-observer compliance. Florence Nightingale J Nurs 2017;25(2):111-8. google scholar
24. 24. Avşar P, Karadağ A. Efficacy and cost-effectiveness analysis of evidence-based nursing interventions to maintain tissue integrity to prevent pressure ulcers and incontinence-associated dermatitis. Worldviews Evid Based Nurs 2018;15(1):54-61. google scholar
25. 25. Demarre L, Verhaeghe S, Van Hecke A, Clays E, Grypdonck M, Beeckman D. Factors predicting the development of pressure ulcers in an at-risk population who receive standardized preventive care: secondary analyses of a multicentre randomised controlled trial. J Adv Nurs 2015;71(2):391-403. google scholar
26. 26. Gray M, Giuliano KK. Incontinence-associated dermatitis, characteristics and relationship to pressure injury: a multisite epidemiologic analysis. J Wound Ostomy Continence Nurs 2018;45(1):63-7. google scholar
27. 27. Kottner J, Beeckman D. Incontinence-associated dermatitis and pressure ulcers in geriatric patients. Giornale italiano di dermatologia e venereologia: organo ufficiale. G Ital Dermatol Venereol 2015;150(6):717-29. google scholar
28. 28. Kottner J, Blume-Peytavi U, Lohrmann C, Halfens R. Associations between individual characteristics and incontinence-associated dermatitis: A secondary data analysis of a multi-centre prevalence study. Int J Nurs Stud 2014;51(10):1373-80. google scholar
29. 29. Coyer F, Gardner A, Doubrovsky A. An interventional skin care protocol (InSPiRE) to reduce incontinence-associated dermatitis in critically ill patients in the intensive care unit: A before and after study. Intensive Crit Care Nurs 2017;40:1-10. google scholar
30. 30. Boronat-Garrido X, Kottner J, Schmitz G, Lahmann N. Incontinence-associated dermatitis in nursing homes: prevalence, severity, and risk factors in residents with urinary and/or fecal incontinence. J Wound Ostomy and Continence Nurs 2016;43(6):630-5. google scholar
31. 31. Van Damme N, Clays E, Verhaeghe S, Van Hecke A, Beeckman D. Independent risk factors for the development of incontinence-associated dermatitis (category 2) in critically ill patients with fecal incontinence: A cross-sectional observational study in 48 ICU units. Int J Nurs Stud 2018;81:30-9. google scholar
32. 32. Arnold-Long M, Reed L, Dunning K, Ying J. Incontinence-associated dermatitis (IAD) in a long-term acute care (LTAC) facility: findings from a 12 week prospective study. J Wound Ostomy Continence Nurs 2012;39(3):318-27. google scholar
33. 33. Beeckman D. A decade of research on Incontinence-Associated Dermatitis (IAD): Evidence, knowledge gaps and next steps. J Tissue Viability 2017;26(1):47-56. google scholar
34. 34. Chianca TCM, Gonçales PC, Salgado PO, Machado BDO, Amorim GL, Alcoforado CLGC. Incontinence-associated dermatitis: a cohort study in critically ill patients. Rev Lat Am Enfermagem. 2016;37:68075. google scholar